Found: 211
Select item for more details and to access through your institution.
Response patterns and impact of MRD in patients with IDH1/2-mutated AML treated with venetoclax and hypomethylating agents.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00915-6
- By:
- Publication type:
- Article
A Phase I study of Milademetan (DS3032b) in combination with low dose cytarabine with or without venetoclax in acute myeloid leukemia: Clinical safety, efficacy, and correlative analysis.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00871-1
- By:
- Publication type:
- Article
Successful treatment of intracranial hemorrhage with recombinant activated factor VII in a patient with newly diagnosed acute myeloid leukemia: a case report and review of the literature.
- Published in:
- 2015
- By:
- Publication type:
- Case Study
A single case of Rosai-Dorfman disease marked by pathologic fractures, kidney failure, and liver cirrhosis treated with single-agent cladribine.
- Published in:
- Frontiers in Oncology, 2014, v. 4, p. 1, doi. 10.3389/fonc.2014.00297
- By:
- Publication type:
- Article
Extramedullary acute myeloid leukemia: leukemic pleural effusion, case report and review of the literature.
- Published in:
- Frontiers in Oncology, 2014, v. 4, p. 1, doi. 10.3389/fonc.2014.00130
- By:
- Publication type:
- Article
Tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemia: a single-institution experience.
- Published in:
- Journal of Hematology & Oncology, 2019, v. 12, n. 1, p. N.PAG, doi. 10.1186/s13045-018-0686-1
- By:
- Publication type:
- Article
Overcoming Tagraxofusp-Erzs Monotherapy Resistance in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) in a Real-World Clinical Setting.
- Published in:
- Journal of Immunotherapy & Precision Oncology, 2024, v. 7, n. 3, p. 205, doi. 10.36401/jipo-23-43
- By:
- Publication type:
- Article
Abdominal venous thrombosis presenting in myeloproliferative neoplasm with JAK2 V617F mutation: a case report.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Myeloproliferative neoplasms in the adolescent and young adult population: A comprehensive review of the literature.
- Published in:
- British Journal of Haematology, 2024, v. 205, n. 1, p. 48, doi. 10.1111/bjh.19557
- By:
- Publication type:
- Article
Phase 1/2 study of CPX‐351 for patients with Int‐2 or high risk International Prognostic Scoring System myelodysplastic syndromes and chronic myelomonocytic leukaemia after failure to hypomethylating agents.
- Published in:
- British Journal of Haematology, 2024, v. 204, n. 3, p. 898, doi. 10.1111/bjh.19193
- By:
- Publication type:
- Article
Phenotypic subtypes of leukaemic transformation in chronic myelomonocytic leukaemia.
- Published in:
- British Journal of Haematology, 2023, v. 203, n. 4, p. 581, doi. 10.1111/bjh.19060
- By:
- Publication type:
- Article
Allogeneic stem cell transplant for patients with myeloproliferative neoplasms in blast phase: improving outcomes in the recent era.
- Published in:
- British Journal of Haematology, 2021, v. 193, n. 5, p. 1004, doi. 10.1111/bjh.17423
- By:
- Publication type:
- Article
Treating Rosai–Dorfman disease and RAS‐associated autoimmune leucoproliferative disorder with malignant transformation.
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 3, p. 667, doi. 10.1111/bjh.17258
- By:
- Publication type:
- Article
Atypical cases of necrotizing sweet syndrome in patients with myelodysplastic syndrome and acute myeloid leukaemia.
- Published in:
- British Journal of Haematology, 2020, v. 191, n. 1, p. e10, doi. 10.1111/bjh.16937
- By:
- Publication type:
- Article
Sudden blastic transformation in treatment‐free remission chronic myeloid leukaemia.
- Published in:
- British Journal of Haematology, 2019, v. 187, n. 4, p. 543, doi. 10.1111/bjh.16245
- By:
- Publication type:
- Article
SMAC mimetics as potential cancer therapeutics in myeloid malignancies.
- Published in:
- British Journal of Haematology, 2019, v. 185, n. 2, p. 219, doi. 10.1111/bjh.15829
- By:
- Publication type:
- Article
Ocular extramedullary myeloid leukaemia.
- Published in:
- British Journal of Haematology, 2018, v. 180, n. 5, p. 738, doi. 10.1111/bjh.14430
- By:
- Publication type:
- Article
Prognostic significance of the Medical Research Council cytogenetic classification compared with the European LeukaemiaNet risk classification system in acute myeloid leukaemia.
- Published in:
- British Journal of Haematology, 2015, v. 170, n. 4, p. 590, doi. 10.1111/bjh.13319
- By:
- Publication type:
- Article
Clinical characteristics and outcomes in patients with acute promyelocytic leukaemia and hyperleucocytosis.
- Published in:
- British Journal of Haematology, 2015, v. 168, n. 5, p. 646, doi. 10.1111/bjh.13189
- By:
- Publication type:
- Article
Salvage therapy using FLT3 inhibitors may improve long-term outcome of relapsed or refractory AML in patients with FLT3- ITD.
- Published in:
- British Journal of Haematology, 2013, v. 161, n. 5, p. 659, doi. 10.1111/bjh.12299
- By:
- Publication type:
- Article
A phase 2 trial of mini‐hyper‐CVD, blinatumomab, and ponatinib in Philadelphia positive acute lymphoblastic leukemia.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 11, p. 2229, doi. 10.1002/ajh.27463
- By:
- Publication type:
- Article
Targetable genetic abnormalities in patients with acute myeloblastic leukemia across age groups.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 4, p. 792, doi. 10.1002/ajh.27236
- By:
- Publication type:
- Article
Phase II study of cladribine, idarubicin, and ara‐C (CLIA) with or without sorafenib as initial therapy for patients with acute myeloid leukemia.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 11, p. 1711, doi. 10.1002/ajh.27054
- By:
- Publication type:
- Article
Characteristics and outcomes of patients with chronic myeloid leukemia and T315I mutation treated in the pre‐ and post‐ponatinib era.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 10, p. 1619, doi. 10.1002/ajh.27037
- By:
- Publication type:
- Article
Frontline combination of ponatinib and hyper‐CVAD in Philadelphia chromosome‐positive acute lymphoblastic leukemia: 80‐months follow‐up results.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 3, p. 493, doi. 10.1002/ajh.26816
- By:
- Publication type:
- Article
Common kinase mutations do not impact optimal molecular responses in core binding factor acute myeloid leukemia treated with fludarabine, cytarabine, and G‐CSF based regimens.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 3, p. E53, doi. 10.1002/ajh.26811
- By:
- Publication type:
- Article
Implications of RAS mutational status in subsets of patients with newly diagnosed acute myeloid leukemia across therapy subtypes.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 12, p. 1599, doi. 10.1002/ajh.26731
- By:
- Publication type:
- Article
Retrospective comparison of survival and responses to Fludarabine, Cytarabine, GCSF (FLAG) in combination with gemtuzumab ozogamicin (GO) or Idarubicin (IDA) in patients with newly diagnosed core binding factor (CBF) acute myelogenous leukemia: MD Anderson experience in 174 patients
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 11, p. 1427, doi. 10.1002/ajh.26700
- By:
- Publication type:
- Article
Low‐dose dasatinib 50 mg/day versus standard‐dose dasatinib 100 mg/day as frontline therapy in chronic myeloid leukemia in chronic phase: A propensity score analysis.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 11, p. 1413, doi. 10.1002/ajh.26689
- By:
- Publication type:
- Article
Venetoclax combined with FLAG‐IDA induction and consolidation in newly diagnosed acute myeloid leukemia.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 8, p. 1035, doi. 10.1002/ajh.26601
- By:
- Publication type:
- Article
Urgent cytoreduction for newly diagnosed acute myeloid leukemia patients allows acquisition of pretreatment genomic data and enrollment on investigational clinical trials.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 7, p. 885, doi. 10.1002/ajh.26572
- By:
- Publication type:
- Article
Treatment‐free remission in patients with chronic myeloid leukemia following the discontinuation of tyrosine kinase inhibitors.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 7, p. 856, doi. 10.1002/ajh.26550
- By:
- Publication type:
- Article
Activity of decitabine as maintenance therapy in core binding factor acute myeloid leukemia.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 5, p. 574, doi. 10.1002/ajh.26496
- By:
- Publication type:
- Article
Improved outcomes among newly diagnosed patients with FMS‐like tyrosine kinase 3 internal tandem duplication mutated acute myeloid leukemia treated with contemporary therapy: Revisiting the European LeukemiaNet adverse risk classification.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 3, p. 329, doi. 10.1002/ajh.26451
- By:
- Publication type:
- Article
Venetoclax and hypomethylating agents in older/unfit patients with blastic plasmacytoid dendritic cell neoplasm.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 2, p. E62, doi. 10.1002/ajh.26417
- By:
- Publication type:
- Article
Inotuzumab ozogamicin with bosutinib for relapsed or refractory Philadelphia chromosome positive acute lymphoblastic leukemia or lymphoid blast phase of chronic myeloid leukemia.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 8, p. 1000, doi. 10.1002/ajh.26238
- By:
- Publication type:
- Article
Long‐term results of low‐intensity chemotherapy with clofarabine or cladribine combined with low‐dose cytarabine alternating with decitabine in older patients with newly diagnosed acute myeloid leukemia.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 8, p. 914, doi. 10.1002/ajh.26206
- By:
- Publication type:
- Article
Clinical, genomic, and transcriptomic differences between myelodysplastic syndrome/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis (MDS/MPN‐RS‐T) and myelodysplastic syndrome with ring sideroblasts (MDS‐RS).
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 7, p. E246, doi. 10.1002/ajh.26182
- By:
- Publication type:
- Article
Venetoclax with decitabine vs intensive chemotherapy in acute myeloid leukemia: A propensity score matched analysis stratified by risk of treatment‐related mortality.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 3, p. 282, doi. 10.1002/ajh.26061
- By:
- Publication type:
- Article
Clinical outcomes and influence of mutation clonal dominance in oligomonocytic and classical chronic myelomonocytic leukemia.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 2, p. E50, doi. 10.1002/ajh.26044
- By:
- Publication type:
- Article
Early detection of transformation to BPDCN in a patient with MDS.
- Published in:
- Experimental Hematology & Oncology, 2018, v. 7, n. 1, p. N.PAG, doi. 10.1186/s40164-018-0117-6
- By:
- Publication type:
- Article
Implementation of a Pan-Genomic Approach to Investigate Holobiont-Infecting Microbe Interaction: A Case Report of a Leukemic Patient with Invasive Mucormycosis.
- Published in:
- PLoS ONE, 2015, v. 10, n. 10, p. 1, doi. 10.1371/journal.pone.0139851
- By:
- Publication type:
- Article
Real-world treatments and thrombotic events in polycythemia vera patients in the USA.
- Published in:
- Annals of Hematology, 2023, v. 102, n. 3, p. 571, doi. 10.1007/s00277-023-05089-6
- By:
- Publication type:
- Article
Phase II study of single-agent nivolumab in patients with myelofibrosis.
- Published in:
- Annals of Hematology, 2021, v. 100, n. 12, p. 2957, doi. 10.1007/s00277-021-04618-5
- By:
- Publication type:
- Article
The co-occurrence of driver mutations in chronic myeloproliferative neoplasms.
- Published in:
- Annals of Hematology, 2018, v. 97, n. 11, p. 2071, doi. 10.1007/s00277-018-3402-x
- By:
- Publication type:
- Article
Association of bone marrow fibrosis with inferior survival outcomes in chronic myelomonocytic leukemia.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Patient characteristics and outcomes in adolescents and young adults with classical Philadelphia chromosome-negative myeloproliferative neoplasms.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Diagnosing and Treating Blastic Plasmacytoid Dendritic Cell Neoplasm in a Resource-Limited Setting.
- Published in:
- Oncology (08909091), 2024, v. 38, p. 104, doi. 10.46883/2024.25921014
- By:
- Publication type:
- Article
Immunophenotypic and Molecular Features of Acute Myeloid Leukemia with Plasmacytoid Dendritic Cell Differentiation Are Distinct from Blastic Plasmacytoid Dendritic Cell Neoplasm.
- Published in:
- Cancers, 2022, v. 14, n. 14, p. N.PAG, doi. 10.3390/cancers14143375
- By:
- Publication type:
- Article
CD123 and More: How to Target the Cell Surface of Blastic Plasmacytoid Dendritic Cell Neoplasm.
- Published in:
- Cancers, 2022, v. 14, n. 9, p. N.PAG, doi. 10.3390/cancers14092287
- By:
- Publication type:
- Article